Warning letterPosted June 3, 2025
FDA warning letter to Anti L’Age
CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated
FDA posted a warning letter to Anti L’Age on June 3, 2025; the letter is dated April 17, 2025. Subject: CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated. Issuing office: Human Foods Program.
On the record
- Company
- Anti L’Age
- Subject
- CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated
- Issuing office
- Human Foods Program
- Letter dated
- 2025-04-17
- Posted by FDA
- 2025-06-03
- Source
- FDA warning letters ↗
CFR cited
The record cites 18 sections of 21 CFR Parts 101 and 111.
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch Anti L’Age
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Anti L’Age.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.